Asher Bio
We build better immunotherapies
Based based in San Francisco, CA, USA; San Carlos, CA, USA, Asher Bio works in healthcare, founded in 2019.
Profile
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases.
Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
Asher Bio is positioned in healthcare, a segment that rewards a clear, focused offering.
Its base of operations is San Francisco, CA, USA; San Carlos, CA, USA.
Directory data places it at the Summer 2019 stage.
Its team size is recorded as 3 employees.
It has disclosed roughly $218.2M in funding.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA; San Carlos, CA, USA |
| Country | USA |
| Founded | 2019 |
| Employees | 3 |
| Stage | Summer 2019 |
| Total funding | $218,150,000 |
Website: www.asherbio.com
Browse related
Create a free account